Perspectives on Development and Regulation of Therapeutic Products for CED-Based Therapy of Neurodegenerative Diseases

E-ISSN： 1873-4316|17|6|495-512

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.17, Iss.6, 2016-05, pp. : 495-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AMPK in Neurodegenerative Diseases: Implications and Therapeutic Perspectives

Current Drug Targets, Vol. 17, Iss. 8, 2016-06 ,pp. : 890-907

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 2, 2008-04 ,pp. : 187-210

Bentham Science Publishers

Access to resources Recommend Favorite

Catalpol: A Potential Therapeutic for Neurodegenerative Diseases

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-04 ,pp. : 1278-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Immunopathogenesis of Neurodegenerative Diseases: Current Therapeutic Models of Neuroprotection with Special Reference to Natural Products

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 34-42

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis modulators in the therapy of neurodegenerative diseases

By Deigner H-P. Haberkorn U. Kinscherf R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 747-764

Informa Healthcare

Access to resources Recommend Favorite